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Background: The objective of the study was to estimate the personal usage of long-acting reversible 
contraception (LARC) among obstetrics and gynecology (Ob/Gyn) residents in the United States 
and compare usage between programs with and without a Ryan Residency Training Program (Ryan 
Program), an educational program implemented to enhance resident training in family planning.
Materials and methods: We performed a web-based, cross-sectional survey to explore con-
traceptive use among Ob/Gyn residents between November and December 2014. Thirty-two 
Ob/Gyn programs were invited to participate, and 24 programs (75%) agreed to participate. We 
divided respondents into two groups based on whether or not their program had a Ryan Program. 
We excluded male residents without a current female partner as well as residents who were 
currently pregnant or trying to conceive. We evaluated predictors of LARC use using bivariate 
analysis and multivariable Poisson regression.
Results: Of the 638 residents surveyed, 384 (60.2%) responded to our survey and 351 were 
eligible for analysis. Of those analyzed, 49.3% (95% confidence interval [CI]: 44.1%, 54.5%) 
reported current LARC use: 70.0% of residents in Ryan Programs compared to 26.8% in non-
Ryan Programs (RR
adj
 2.14, 95% CI 1.63–2.80). Residents reporting a religious affiliation were 
less likely to use LARC than those who described themselves as non-religious (RR
adj
 0.76, 
95% CI 0.64–0.92). Of residents reporting LARC use, 91% were using the levonorgestrel 
intrauterine device.
Conclusion: LARC use in this population of women’s health specialists is substantially higher 
than in the general population (49% vs. 12%). Ob/Gyn residents in programs affiliated with the 
Ryan Program were more likely to use LARC. 
Keywords: contraception, education, family planning, LARC, Ob/Gyn residents
Introduction
Long-acting reversible contraception (LARC) methods are the most effective revers-
ible methods of pregnancy prevention.1 The three commonly used LARC methods 
available in the United States (US) include the copper and levonorgestrel-containing 
intrauterine devices (IUDs) and the subdermal etonogestrel implant. LARC uptake has 
been particularly high within the family planning community, with one study demon-
strating 41.7% of sampled providers using a LARC method.2 Uptake in the general 
population is not nearly as high with recent data demonstrating an increase from 2.4% 
in 2002 to 8.5% in 2009.3 These findings were corroborated by the recent data from 
the National Survey of Family Growth showing that the percentage of women using 
LARC were stable at 1.5% from 1988 until 2002 and increased to 7.2% by 2011.4 In 
2015, the Guttmacher Institute quoted the most recent rate of LARC use in the US as 
Correspondence: rachel e Zigler
Department of Obstetrics and 
gynecology, Division of Clinical research 
and Family Planning, Washington 
University in st. louis, 4533 Clayton 
Avenue, Campus Box 8219, st. louis, 
MO 63110, UsA
Tel +1 314 747 6409
Fax +1 314 747 6722
email ziglerr@wudosis.wustl.edu
Journal name: Open Access Journal of Contraception
Article Designation: Original Research
Year: 2017
Volume: 8
Running head verso: Zigler et al
Running head recto: Long-acting reversible contraception use
DOI: http://dx.doi.org/10.2147/OAJC.S126771
Open Access Journal of Contraception 2017:8submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2
Zigler et al
11.6%.5 Low uptake of LARC can be attributed to many fac-
tors including cost, patient knowledge and access, and, lastly, 
provider knowledge and bias. The Contraceptive CHOICE 
Project demonstrated that when these barriers were removed, 
LARC uptake could be as high as 75%.6,7 While all forms 
of contraception are important and should be discussed with 
patients, improving access to LARC has been identified by 
the family planning community as one strategy to reduce 
unintended pregnancy and abortion rates.7–9
Obstetrics and gynecology (Ob/Gyn) residents may be 
among the most educated consumers of evidence-based fam-
ily planning. Their training focuses on women’s health, which 
specifically includes the provision of contraception. This, in 
turn, should reflect a highly informed and knowledgeable 
population of physicians and consumers. However, exposure 
to contraception is not standardized across residency training 
programs in the US. In 1999, the Kenneth J. Ryan Residency 
Training Program (Ryan Program) was launched to integrate 
and enhance family planning training for Ob/Gyn residents 
in the US and Canada.10 The Ryan Program provides an 
opportunity for Ob/Gyn residents to have a structured expe-
rience in abortion and contraception education. To date, 80 
of the 243 (40%) US Ob/Gyn residencies have incorporated 
the Ryan Program. While less than one-half of residencies 
have a Ryan Program, the Accreditation Council of Graduate 
Medical Education still requires that Ob/Gyn residency pro-
grams provide a structured didactic and clinical educational 
experience in all methods of family planning, including all 
reversible and permanent methods of contraception.11
Our study estimated the personal contraceptive use of 
Ob/Gyn residents in the US and the percentage of residents 
using the most effective reversible contraceptive methods. 
We also evaluated the association of formalized contraceptive 
training through the Ryan Program with the contraceptive 
choices of current Ob/Gyn residents and/or their partners. We 
hypothesized that a greater percentage of Ob/Gyn residents 
were using LARC methods in comparison to the general 
population and, secondarily, that residents exposed to the 
Ryan Program would be more likely to use LARC methods 
than residents in programs without Ryan training.
Materials and methods
study design and data collection
Between November and December 2014, we performed a 
nationwide survey of Ob/Gyn residents using a convenience 
sample obtained from the American Congress of Obstetrics 
and Gynecology website directory (www.acog.org).12 The 
Institutional Review Board of Washington University in 
St. Louis approved this study for exempt status prior to partici-
pant recruitment. For efficiency, we gave preference to larger 
programs with a greater number of residents in order to meet 
our required sample size. Programs were selected based on 
whether or not they had a Ryan Program. This information was 
obtained from the Ryan Program website (www.ryanprogram.
org).13 We attempted to balance the Ryan/non-Ryan groups 
by geographic region (e.g., Northeast, West, Midwest, etc.). 
We approached 32 programs (3 with religious affiliation, 29 
without religious affiliation), and ultimately the web-based 
survey (developed using Research Electronic Data Capture) 
was distributed to residents in 24 programs (638 residents 
out of 5,000 active US residents, 13%) after introducing the 
project to residency coordinators or program directors.14 Two 
electronic invitations were sent to residency coordinators and/
or program directors. Study information and survey links were 
sent via email to residents by their program coordinator and/
or director. Consent was implied by survey participation as it 
was described as voluntary. Respondents were compensated 
with a $5 electronic gift card after survey completion.
Our survey took approximately 10 minutes to complete. 
The survey collected demographic characteristics as well as 
current relationship status and respondent’s religious affili-
ation. Respondents were asked if they or their partner were 
currently pregnant or trying to conceive. If the respondent 
(or the respondent’s partner) was not currently pregnant or 
trying to conceive, she/he was asked about her/his partner’s 
current contraceptive method. Finally, respondents were 
asked about factors affecting their method of choice. 
Data analysis
We included all respondents in our initial analysis comparing 
resident characteristics in Ryan versus non-Ryan Programs. 
However, in our analysis of contraceptive use, we excluded 
residents who were pregnant or trying to conceive, as well as 
male respondents without female partners. Female respon-
dents with female partners were included, as our assessment 
of contraceptive use was not limited to pregnancy prevention.
All statistical analyses were performed using Stata 
Software (v.11; StataCorp, College Station, Texas, USA). 
Demographic characteristics were presented as means, stan-
dard deviations, and percentages stratified by Ryan Program 
status. Student’s t-tests, chi-square tests, and Fisher’s exact 
tests were used where appropriate to compare characteris-
tics of Ryan Program residents to residents from programs 
without a Ryan. We compared demographic characteristics 
between respondents using a LARC method and those using 
a non-LARC method. We evaluated predictors of LARC 
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use using bivariate analysis and Poisson regression with 
robust error variance. This multivariable method provides an 
unbiased estimate of the relative risk (RR) given a common 
outcome (greater than 10%). Significant factors identified 
in the bivariate analysis were included in the final adjusted 
multivariable regression model.
We calculated our sample size based on an alpha level 
of 0.05 and power of 80%. Use of LARC by non-Ryan resi-
dents was estimated to be 15%. Assuming a 2-fold increase 
in LARC use among Ryan Program residents compared to 
non-Ryan residents, we needed a sample size of 118 residents 
per group. Given our sample of more than 180 per group, we 
had >90% power to detect a statistically significant difference 
(type II error rate <10%).
Results
Of the 32 Ob/Gyn residency training programs invited to 
participate, 11 sites with Ryan Programs and 13 sites with-
out a Ryan Program (total=24 programs or 75%) agreed to 
participate. Of the 638 residents in these 24 programs, 384 
completed the web-based survey, with a survey response 
rate of 60.2%.
In our analysis of Ryan versus non-Ryan respondents, we 
excluded 7 male respondents without female partners. Twenty-
six participants were also excluded as they were pregnant or 
trying to conceive. Thus, we were left with an analytic sample 
of 351 participants (183 participants in Ryan Programs and 
168 in non-Ryan Programs; Figure 1). Residents in Ryan 
and non-Ryan Programs were similar with the exception of 
384 survey
respondents
(24 programs)
377
analyzed
(97%)
7 male respondents
without female partner
191 respondents
in Ryan Programs
(51%)
186 respondents in
non-Ryan Programs
(49%)
8 trying to
conceive/
currently
pregnant
(4%)
183 not
attempting
conception
(96%)
18 trying to
conceive/
currently
pregnant
(10%)
168 not
attempting
conception
(90%)
128
using
LARC
(70%)
55 using
non-LARC
or no
method
(30%)
45
using
LARC
(27%)
123
using
non-LARC
or no method
(73%)
Distributed
to 32
programs
Figure 1 Participant flow diagram.
Abbreviation: lArC, long-acting reversible contraception; ryan Program, ryan residency Training Program.
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reported personal religious affiliation, number of residents 
pregnant or trying to conceive, and LARC use (Table 1). 
Of the eligible respondents, when asked to name their 
primary method of contraception, 49.3% (173/351) reported 
using a LARC method, 43.6% (153/351) reported using a 
Table 2 Current contraceptive method use (n=351)
Method Frequency %
LARC 173 49
levonorgestrel intrauterine device 158 45
Copper intrauterine device 8 2
subdermal implant 7 2
Non-LARC 153 44
Depot medroxyprogesterone acetate 3 1
Pills 94 27
Patch 1 0
ring 27 8
Condoms 16 5
Abstinence 5 1
sterilization (male or female) 1 0
Other 6 2
No method 25 7
Abbreviation: lArC, long-acting reversible contraception.
non-LARC method, and 7.1% (25/351) reported not using 
a method. The most common LARC method used was 
the levonorgestrel IUD (158/173, 91.3% of LARC users; 
158/351, 45% of total cohort). The most commonly reported 
non-LARC method was the combined oral contraceptive 
pill (94/153, 61.4% of non-LARC users; 94/351, 26.8% of 
total cohort). Table 2 demonstrates the method mix used by 
respondents.
Demographic comparisons between LARC and non-
LARC contraceptive users are presented in Table 3. LARC 
use was reported by 70.0% (128/183) of residents affiliated 
with a Ryan Program and 26.8% (45/168) by non-Ryan 
Program residents (P<0.01). When we compared LARC 
and non-LARC (including no method) users, we found no 
statistically significant differences in age, race, marital status, 
or current level of training. The 2 groups differed in response 
to the most important reason they identified for choosing their 
contraceptive method (Tables 3 and 4): respondents using 
LARC reported the effectiveness of the method (82/173, 
47.4%) and convenience/ease of use (43/173, 24.9%) to 
be the most important factors. Non-LARC users reported 
menstrual symptom control, including heavy bleeding, 
and effectiveness of the method to be the most important 
factors: 31.5% (56/178) and 28.1% (50/178), respectively. 
After adjusting for differences among the groups, including 
religion and reason for method of choice, residents in Ryan 
Programs were found to be 2 times more likely (RR 2.14, 
95% confidence interval 1.63–2.80) to use a LARC method 
than their non-Ryan counterparts (Table 4). 
Discussion
In this analysis of contraceptive use, we found that approxi-
mately half of Ob/Gyn residents were using LARC methods, 
Table 1 Characteristics of residents in ryan vs. non-ryan 
affiliated Programs, all respondents (n=377)
Characteristic Ryan  
(n=191)
Non-Ryan 
(n=186)
P-value
Mean SD Mean SD
Age 29.0 2.1 28.9 2.2 0.62
N % N %  
Race     0.29
Black 9 4.7 13 7.0  
White 154 81.1 155 83.3  
Others 27 14.2 18 9.7  
Ethnicity     0.06
hispanic 14 7.4 5 2.7  
non-hispanic 175 92.6 179 97.3  
Marital status     0.89
Married 87 45.5 89 47.8  
not married but partnered 74 38.7 68 36.6  
no partner 30 15.7 29 15.6  
Respondent/Partner sex 0.16
Female respondent, male 
partner
147 77.0 133 71.5
Female respondent, female 
partner
0 0 3 1.6
Female respondent, no partner 31 16.2 30 16.1
Male respondent, female 
partner
13 6.8 20 10.8
Current level of training     0.26
Postgraduate year 1 51 26.7 35 18.8  
Post graduate year-2 52 27.2 50 26.9  
Postgraduate year 3 43 22.5 46 24.7  
Postgraduate year 4 45 23.6 55 29.6  
Religion     <0.01
Agnostic, atheist, and none 70 36.6 36 19.4  
hindu, islamic, Buddhist, other 16 8.4 11 5.9  
Catholic 24 12.6 49 26.3  
Christian, Mormon 33 17.3 66 35.5  
Jewish 29 15.2 8 4.3  
Protestant 19 9.9 16 8.6  
Religion dichotomized     <0.01
Agnostic, atheist, and none 70 36.6 36 19.4  
Any religion 121 63.4 150 80.6  
Currently pregnant or 
trying to conceive
    0.04
no 183 95.8 168 90.3  
Yes 8 4.2 18 9.7  
Current LARCa use     <0.01
no 55 30.1 123 73.2  
Yes 128 70.0 45 26.8  
Notes: Column percentages do not always equal 100% as some survey questions 
were not answered by the participants.
aLARC including IUDs or implants.
Abbreviations: sD, standard deviation; lArC, long-acting reversible contraception; 
iUD, intrauterine device; ryan Pragram, ryan residency Training Program.
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Multiple studies have shown that level of knowledge 
regarding contraception is an important factor in personal 
contraceptive method choice.15,16 We found an association 
between exposure to the Ryan Program and LARC use. 
Residents who are more comfortable with the evidence sup-
porting use of LARC methods may be more comfortable 
using the method themselves. A survey of family planning 
providers supports this conclusion and revealed that 42% of 
these providers were themselves using a LARC method.15 Two 
additional recent international surveys of female healthcare 
providers corroborate these findings and one of these stud-
ies concluded that personal contraceptive choice influenced 
contraceptive recommendations to patients.17,18
LARC uptake in the US is increasing; however, it is still 
lower than many developed countries.19 Recent reports have 
shown that use of LARC methods has grown 5-fold since 
2002.4 However, the most recent national data indicate that 
only 11.6% of women using contraception are using an IUD 
or implant.5 
Our study describes the contraceptive use of Ob/Gyn 
residents in the US and evaluates the association of a for-
malized contraception and abortion curriculum on those 
method choices. This study is unique in that the respon-
dents are not only highly educated and insured, but are also 
currently in training programs to become practicing Ob/
Gyns. Having insurance as well as familiarity with current 
evidence theoretically eliminates two of the most common 
barriers to increased LARC uptake. When not covered by 
insurance, LARC is associated with an initial substantial 
out-of-pocket expense and decreased LARC use.20 Although 
it is possible that some respondents, particularly those train-
ing at a religiously affiliated residency programs, may not 
have contraceptive coverage, we did not specifically ask this 
question and therefore were unable to control this variable 
in the analysis. 
Table 3 Characteristics of study population by use of lArC vs. 
non-lArC method (n=351)
Characteristic LARC 
(n=173)
Non-LARC/no 
method (n=178)
P-value
Mean SD Mean SD
Age 29.0 2.4 28.9 1.9 0.63
N % N %
Race    0.45
Black 8 4.6 14 7.9
White 144 83.2 143 80.8
Others 21 12.2 20 11.3
Ethnicity    0.44
hispanic 11 6.4 8 4.5
non-hispanic 161 93.6 169 95.5
Marital status    0.68
Married 76 43.9 75 42.1
not married but 
partnered
71 41.1 70 39.3
no partner 26 15.0 33 18.6
Current level of 
training
   0.47
Postgraduate year 1 47 27.1 37 20.8
Postgraduate year 2 42 24.3 49 27.5
Postgraduate year 3 42 24.3 41 23.0
Postgraduate year 4 42 24.3 51 28.7
Personal religion     <0.01
Agnostic, Atheist, and 
none
67 38.7 35 19.7
hindu, islamic, Buddhist, 
other
11 6.4 12 6.7
Catholic 28 16.2 42 23.6
Christian, Mormon 36 20.8 55 30.9
Jewish 14 8.1 20 11.2
Protestant 17 9.8 14 7.9
Personal religion, 
dichotomized
    <0.01
Agnostic, atheist, and 
none
67 38.7 35 19.7
Any religion 106 61.3 143 80.3
Most important 
reason for method 
choice
    <0.01
effective pregnancy 
prevention
82 47.4 50 28.1
Convenient and easy 
to use
43 24.9 41 23.1
Method is long acting 21 12.1 2 1.1
Bleeding, symptom, or 
menstrual control
22 12.7 56 31.5
Others 5 2.9 28 15.7
Notes: Column percentages do not always equal 100% as some survey questions 
were not answered by the participants.
Abbreviations: sD, standard deviation; lArC, long-acting reversible contraception.
Table 4 Factors associated with current lArC use
Factor Adjusted model
RR 95% CI
ryan Program 2.14 1.63 2.80
Personal religion, dichotomized
Agnostic, Atheist, and none
All other religions 0.76 0.64 0.92
Most important reasons for method choice
Effective pregnancy prevention 3.48 1.46 8.28
Convenient and easy to use 3.05 1.26 7.39
Method is long acting 4.14 1.75 9.80
Bleeding, symptom, or menstrual control 1.81 0.72 4.57
Abbreviations: lArC, long-acting reversible contraception; rr, relative risk; 
CI, confidence interval; Ryan Program, Ryan Residency Training Program.
a rate more than 4 times higher than the general population.5 
This percentage is remarkable, given current IUD and implant 
use in the US. In addition, residents in Ryan-affiliated train-
ing programs were twice as likely to use LARC as residents 
in non-affiliated programs. 
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Our study had several strengths. Achieving adequate 
responses to electronic surveys is difficult, with the mean 
historical response rate being 37%.21 Our survey response 
rate was 60%, which we believe is sufficiently high to mini-
mize nonresponse bias.22 However, given that only 75% of 
programs agreed to participate, our effective response rate 
was lower (60% * 75%=45%). Even with this consideration, 
we believe this survey to be among the largest contemporary 
surveys of contraceptive use in US Ob/Gyn residents.  Second, 
although prior studies examined knowledge regarding LARC 
as well as personal use of LARC in providers across different 
specialties, our study explored LARC use in Ob/Gyn resi-
dents in training, a group that is expected to be knowledgeable 
regarding all contraceptive methods. 
Our study was not without limitations. We attempted to 
sample a geographically diverse population of both Ryan and 
non-Ryan Programs. However, we did not sample every US 
Ob/Gyn residency program and, for efficiency, we did not invite 
programs with a small number of residents. Yet we attempted 
to minimize sample bias by stratifying programs by geographic 
region and Ryan affiliation. Second, as a cross-sectional survey, 
we could not establish causality. It is possible, for example, 
that residents who selected a residency with a Ryan Program 
are more likely to use LARC regardless of the educational 
experience of the specific training program. We also did not 
include timing of contraceptive initiation in our analysis; thus, 
we could not establish temporal sequence. In addition, students 
with a greater interest in family planning may be more likely 
to choose a residency program with Ryan training. Lastly, as 
mentioned earlier, there may be residual confounding that we 
were unable to control in our analysis such as contraceptive 
insurance coverage and resident choice of training program.
While our population is not representative of the national 
population, we feel we have demonstrated that, as in the 
Contraceptive CHOICE project, when knowledge, access, 
and financial barriers to contraception are removed, women 
are more likely to choose the most effective contraceptive 
methods.7,8,15 Our study suggests that exposure to formalized 
and evidence-based contraceptive and abortion curriculum 
may result in a higher uptake of these methods.
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